Trial Results: China’s Best Vaccine Still Far Below Pfizer, Moderna Success Rates

China’s state-run Global Times on Thursday trumpeted results of a Phase III clinical trial on Sinopharm’s coronavirus vaccines, published by the Journal of the American Medical Association (JAMA), that found the Chinese company’s two leading products were over 70 percent effective. Read more at Breitbart.…